Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced Strategic Co-Development Partnership with Lantheus for Aus Download the PDF here. This post appeared first on investingnews.com 0 Website Related Posts Sona Nanotech’s THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study January 2, 2025 GMV Minerals January 2, 2025 Josef Schachter: Oil Prices to Rise in 2025, Stocks Now at Bargain Levels January 2, 2025
Sona Nanotech’s THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study January 2, 2025